- Home
- NXC vs CBUS Comparison
NXC vs CBUS Comparison
Compare NXC & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXC
- CBUS
- Stock Information
- Founded
- NXC 1992
- CBUS 2010
- Country
- NXC United States
- CBUS United States
- Employees
- NXC N/A
- CBUS N/A
- Industry
- NXC Investment Managers
- CBUS Agricultural Chemicals
- Sector
- NXC Finance
- CBUS Industrials
- Exchange
- NXC Nasdaq
- CBUS Nasdaq
- Market Cap
- NXC 82.6M
- CBUS 72.0M
- IPO Year
- NXC N/A
- CBUS 2017
- Fundamental
- Price
- NXC $12.85
- CBUS $1.33
- Analyst Decision
- NXC
- CBUS Strong Buy
- Analyst Count
- NXC 0
- CBUS 3
- Target Price
- NXC N/A
- CBUS $22.00
- AVG Volume (30 Days)
- NXC 17.5K
- CBUS 209.7K
- Earning Date
- NXC 01-01-0001
- CBUS 08-14-2025
- Dividend Yield
- NXC 3.97%
- CBUS N/A
- EPS Growth
- NXC N/A
- CBUS N/A
- EPS
- NXC 0.19
- CBUS N/A
- Revenue
- NXC N/A
- CBUS $4,846,000.00
- Revenue This Year
- NXC N/A
- CBUS $31.23
- Revenue Next Year
- NXC N/A
- CBUS $70.93
- P/E Ratio
- NXC $70.47
- CBUS N/A
- Revenue Growth
- NXC N/A
- CBUS 63.66
- 52 Week Low
- NXC $11.86
- CBUS $1.22
- 52 Week High
- NXC $13.70
- CBUS $7.98
- Technical
- Relative Strength Index (RSI)
- NXC 48.59
- CBUS 43.74
- Support Level
- NXC $12.72
- CBUS $1.29
- Resistance Level
- NXC $12.88
- CBUS $1.41
- Average True Range (ATR)
- NXC 0.08
- CBUS 0.09
- MACD
- NXC -0.00
- CBUS 0.00
- Stochastic Oscillator
- NXC 43.75
- CBUS 54.36
About NXC Nuveen California Select Tax-Free Income Portfolio
Nuveen CA Select Tax Free Income Port is a diversified closed-end management investment company. Its objective is to provide stable dividends exempt from both regular federal and California income taxes, consistent with the preservation of capital by investing in municipal obligations.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.